Actively Recruiting

Age: 45Years - 75Years
All Genders
Healthy Volunteers
NCT06357741

Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis

Led by Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Updated on 2025-04-09

30

Participants Needed

1

Research Sites

230 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

As an activator of inhibiting nuclear factor kB receptor, denosumab affects osteoclast differentiation and development by inhibiting OPG/RANKL-RANK bone regulatory axis pathway. Therefore, denosumab is widely used in the treatment of bone diseases such as osteoporosis. Osteoporosis is closely related to knee osteoarthritis. RANKL-RANK pathway also plays a key role in the pathogenesis of knee osteoarthritis. Therefore, the investigators propose the hypothesis that denosumab can effectively treat knee osteoarthritis.

CONDITIONS

Official Title

Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis

Who Can Participate

Age: 45Years - 75Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with knee osteoarthritis meeting the diagnostic criteria for arthritis
  • No drug contraindications
  • Aged between 45 and 75 years
  • Willing to follow research procedures and cooperate throughout the study
  • Understands the treatment process
  • Able to provide informed consent
  • Has not recently taken medications affecting the study observation
  • Meets all inclusion criteria to participate in the study
Not Eligible

You will not qualify if you...

  • Presence of mental illness
  • Diagnosis of malignant tumors
  • Having other infectious diseases
  • Having metabolic bone disease, diabetes, or hyperthyroidism
  • Unable to actively cooperate in treatment
  • Having low calcium levels (hypocalcemia)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Wuhan Union Hospital

Wuhan, Hubei, China, 430000

Actively Recruiting

Loading map...

Research Team

T

Tian Hongtao, Doctorate

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

15

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here